Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ignasi Jarne-Sanz
Observed names:
Ignasi Jarne,
Jarne-Sanz, Ignasi
Institutions:
Josep Carreras Leukaemia Research Institute,
Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol,
Hospital Universitari Germans Trias i Pujol
Observed institutions:
Consejo Superior de Investigaciones Científicas,
Josep Carreras Leukaemia Research Institute,
Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol,
Institut de Ciències del Mar,
Hospital Universitari Germans Trias i Pujol
ORCID:
0009-0000-7281-4028
Observed ORCID:
0009-0000-7281-4028
OpenAlex ID:
A5093771346
Targeting eEF1A reprograms translation and uncovers broad-spectrum antivirals against cap or m6A protein synthesis routes
2025
·
Elisa Molina Molina
, Joan Josep Bech-Serra
, et al.
·
Nature Communications
·
21
Extraordinary variability in gene activation and repression programs during gonadal sex differentiation across vertebrates
2024
·
Núria Sánchez-Baizán
, Ignasi Jarne-Sanz
, et al.
·
Frontiers in Cell and Developmental Biology
·
15
Integrative multi-omics reveals PARP14 as a key IFNγ-regulated mediator of metastatic progression in Ewing sarcoma
2025
·
Sara Sánchez-Serra
, Mariona Chicón-Bosch
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
·
1
PDF
NF2 lacking exon 11 induced by antisense gene therapy is able to partially recover merlin deficiency in NF2-SWN iPSC-derived spheroid model
2026
·
Gemma Casals-Sendra
, Ignasi Jarne-Sanz
, et al.
·
Molecular Therapy — Nucleic Acids
SOFTWARE: proteomics IJC Functional_Annotation_Collapse: Functional Anotation Collapse 1.0
2026
·
Jarne-Sanz, Ignasi
, Bech-Serra, Joan Josep
Show more works
View as search
Works count:
6
Citation count:
37
H-index:
2
I10-index:
2
Year
Topic
Type